D
Dooreck, MD Educational Health Advisory
Advisory Inquiries
Topic Cluster A • Clinical Hepatology

The Gut-Liver Axis & Metabolic Liver Disease (MASLD)

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of adults worldwide. Explore physician-level breakdowns of hepatic de novo lipogenesis, fructose biochemistry, early metabolic biomarkers, and intestinal tight-junction permeability.

Featured Core Guide

Clinical Pillar Guide • 3,200 Words • Medically Reviewed

The Complete Physician's Guide to Reversing MASLD and MASH: Clinical Staging, Biomarkers & Protocol

A definitive clinical guide detailing the progression from simple hepatic steatosis to inflammatory MASH and fibrosis. Learn how to calculate FIB-4 scores, interpret ultrasound steatosis grading, and apply targeted dietary interventions to reverse liver fat accumulation.

AASLD / ACG Evidence Guidelines • 3,200 Words Clinical Pillar
🔬
AASLD & ACG Evidence Benchmark

Features peer-reviewed PubMed citations, diagnostic decision trees, and resmetirom clinical trial breakdowns.

In-Depth Spoke Analyses

Biochemical Mechanism

Fructose Hepatotoxicity vs Glucose: Why Agave & Syrups Accelerate Liver Steatosis

How fructokinase bypasses normal phosphofructokinase rate-limiting steps in hepatocytes, shunting carbon into rapid de novo lipogenesis.

1,600 Words • Biochemical Mechanism
Biomarkers & Diagnostics

Fasting Insulin & HOMA-IR: The Early Metabolic Markers Routine Bloodwork Misses

Why standard ALT and AST tests remain normal until significant liver inflammation develops, and how calculating HOMA-IR detects insulin resistance years early.

1,500 Words • Biomarkers & Diagnostics
Microbiome & Immunology

Gut Microbiome Endotoxemia: How LPS Leakage Drives Hepatic Inflammation

Lipopolysaccharide translocations across damaged intestinal tight junctions via the portal vein, activating Kupffer cells and TLR-4 pathways.

1,700 Words • Microbiome & Immunology